CC · Chemours Co - Financials
Annual line items from SEC XBRL filings, sourced from EDGAR's Company Facts API with fallback to the quarterly Financial Statement Data Sets. See issuer overview for Form 4 activity and 10-K signals.
Income Statement
| Line item | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.38B | - | $1.50B | $1.61B | $1.37B | - | $1.50B | $1.54B | $1.35B | - |
| Cost of Revenue | $1.17B | - | $1.26B | $1.34B | $1.13B | - | $1.22B | $1.23B | $1.06B | - |
| Gross Profit | $212.00M | - | $233.00M | $278.00M | $236.00M | - | $286.00M | $306.00M | $286.00M | - |
| R&D | $26.00M | - | $26.00M | $28.00M | $27.00M | - | $29.00M | $26.00M | $28.00M | - |
| SG&A | $147.00M | - | $109.00M | $437.00M | $123.00M | - | $135.00M | $139.00M | $142.00M | - |
| Total Operating Expenses | $186.00M | - | $139.00M | $483.00M | $183.00M | - | $265.00M | $168.00M | $174.00M | - |
| D&A | $79.00M | - | $80.00M | $91.00M | $88.00M | - | $78.00M | $74.00M | $71.00M | - |
| Operating Income | $0 | - | $51.00M | ($261.00M) | - | - | ($30.00M) | $82.00M | $67.00M | - |
| Interest Expense | $69.00M | - | $68.00M | $67.00M | $66.00M | - | $69.00M | $66.00M | $63.00M | - |
| Income Tax | $7.00M | - | ($9.00M) | $119.00M | $4.00M | - | ($3.00M) | $12.00M | $15.00M | - |
| Net Income | ($29.00M) | - | $60.00M | ($381.00M) | ($4.00M) | - | ($27.00M) | $70.00M | $52.00M | - |
| EPS - Basic | ($0.19) | - | $0.40 | ($2.54) | ($0.03) | - | ($0.18) | $0.47 | $0.35 | - |
| EPS - Diluted | ($0.19) | - | $0.40 | ($2.54) | ($0.03) | - | ($0.18) | $0.46 | $0.34 | - |
Balance Sheet
| Line item | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $563.00M | $670.00M | $613.00M | $502.00M | $464.00M | $713.00M | $596.00M | $604.00M | $746.00M | $1.20B |
| Accounts Receivable | $645.00M | $562.00M | $817.00M | $813.00M | $704.00M | $619.00M | $825.00M | $788.00M | $692.00M | $509.00M |
| Inventory | $1.54B | $1.57B | $1.55B | $1.56B | $1.55B | $1.47B | $1.44B | $1.37B | $1.39B | $1.35B |
| Accounts Payable | $891.00M | $954.00M | $1.03B | $1.02B | $1.01B | $1.14B | $1.07B | $938.00M | $963.00M | $1.16B |
| Current Assets | $2.93B | $3.00B | $3.21B | $3.10B | $2.93B | $3.03B | $3.08B | $2.94B | $3.60B | $3.83B |
| Total Assets | $7.27B | $7.38B | $7.57B | $7.49B | $7.39B | $7.51B | $7.46B | $7.25B | $7.98B | $8.25B |
| Current Liabilities | $1.61B | $1.69B | $1.88B | $1.85B | $1.67B | $1.80B | $1.78B | $1.56B | $2.23B | $2.49B |
| Long-term Debt | $4.10B | $4.10B | $4.10B | $4.10B | $4.06B | $4.05B | $3.99B | $3.95B | $3.97B | $3.99B |
| Total Liabilities | $7.05B | $7.13B | $7.27B | $7.25B | $6.81B | $6.91B | $6.80B | $6.52B | $7.22B | $7.51B |
| Stockholders' Equity | $215.00M | $250.00M | $298.00M | $237.00M | $579.00M | $604.00M | $657.00M | $723.00M | $752.00M | $737.00M |
| Retained Earnings | $1.18B | $1.22B | $1.31B | $1.26B | $1.66B | $1.72B | $1.76B | $1.83B | $1.80B | $1.78B |
Cash Flow
| Line item | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ($44.00M) | - | - | - | ($112.00M) | - | - | - | ($290.00M) | - |
| Investing Cash Flow | ($44.00M) | - | - | - | ($86.00M) | - | - | - | ($101.00M) | - |
| Financing Cash Flow | ($19.00M) | - | - | - | ($57.00M) | - | - | - | ($54.00M) | - |
| CapEx | $49.00M | - | - | - | $84.00M | - | - | - | $102.00M | - |
| Free Cash Flow | ($93.00M) | - | - | - | ($196.00M) | - | - | - | ($392.00M) | - |
Ratios
| Metric | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Profitability | ||||||||||
| Gross margin | 15.4% | - | 15.6% | 17.2% | 17.3% | - | 19.1% | 19.9% | 21.2% | - |
| Operating margin | 0.0% | - | 3.4% | -16.2% | - | - | -2.0% | 5.3% | 5.0% | - |
| EBITDA margin | 5.7% | - | 8.8% | -10.5% | - | - | 3.2% | 10.1% | 10.2% | - |
| Net margin | -2.1% | - | 4.0% | -23.6% | -0.3% | - | -1.8% | 4.6% | 3.9% | - |
| Free cash flow margin | -6.7% | - | - | - | -14.3% | - | - | - | -29.0% | - |
| FCF / Net income | 3.21 | - | - | - | 49.00 | - | - | - | -7.54 | - |
| R&D / Revenue | 1.9% | - | 1.7% | 1.7% | 2.0% | - | 1.9% | 1.7% | 2.1% | - |
| SG&A / Revenue | 10.6% | - | 7.3% | 27.1% | 9.0% | - | 9.0% | 9.0% | 10.5% | - |
| Effective tax rate | - | - | -17.6% | - | - | - | - | 14.6% | 22.4% | - |
| Return on assets | -0.4% | - | 0.8% | -5.1% | -0.1% | - | -0.4% | 1.0% | 0.7% | - |
| Return on equity | -13.5% | - | 20.1% | -160.8% | -0.7% | - | -4.1% | 9.7% | 6.9% | - |
| Return on invested capital | 0.0% | - | 1.2% | -4.8% | - | - | -0.5% | 1.5% | 1.1% | - |
| Liquidity | ||||||||||
| Current ratio | 1.82 | 1.78 | 1.71 | 1.68 | 1.75 | 1.68 | 1.73 | 1.89 | 1.61 | 1.54 |
| Quick ratio | 0.87 | 0.85 | 0.88 | 0.83 | 0.83 | 0.86 | 0.92 | 1.01 | 0.99 | 1.00 |
| Cash ratio | 0.35 | 0.40 | 0.33 | 0.27 | 0.28 | 0.40 | 0.34 | 0.39 | 0.33 | 0.48 |
| Leverage | ||||||||||
| Debt / Equity | 19.07 | 16.40 | 13.75 | 17.31 | 7.02 | 6.71 | 6.07 | 5.46 | 5.28 | 5.41 |
| Debt / Assets | 0.56 | 0.56 | 0.54 | 0.55 | 0.55 | 0.54 | 0.53 | 0.55 | 0.50 | 0.48 |
| Debt / EBITDA | 51.90 | - | 31.28 | - | - | - | 83.08 | 25.33 | 28.75 | - |
| Interest coverage | 0.0x | - | 0.8x | -3.9x | - | - | -0.4x | 1.2x | 1.1x | - |
| Equity multiplier | 33.80 | 29.53 | 25.40 | 31.59 | 12.77 | 12.44 | 11.36 | 10.03 | 10.61 | 11.20 |
| Liabilities / Assets | 0.97 | 0.97 | 0.96 | 0.97 | 0.92 | 0.92 | 0.91 | 0.90 | 0.91 | 0.91 |
| Efficiency | ||||||||||
| Asset turnover | 0.19 | - | 0.20 | 0.22 | 0.19 | - | 0.20 | 0.21 | 0.17 | - |
| Inventory turnover | 0.76 | - | 0.82 | 0.86 | 0.73 | - | 0.84 | 0.90 | 0.76 | - |
| Days sales outstanding | 170d | - | 199d | 184d | 188d | - | 201d | 187d | 187d | - |
| Days inventory outstanding | 480d | - | 447d | 425d | 500d | - | 432d | 405d | 477d | - |
| Days payable outstanding | 278d | - | 299d | 279d | 324d | - | 321d | 278d | 330d | - |
| Cash conversion cycle | 372d | - | 348d | 330d | 363d | - | 311d | 314d | 334d | - |
| Valuation | ||||||||||
| P / E | - | - | 39.6x | - | - | - | - | 49.1x | 77.2x | - |
| P / B | 15.4x | - | 8.0x | 7.3x | 3.5x | - | 4.6x | 4.7x | 5.2x | - |
| P / S | 2.4x | - | 1.6x | 1.1x | 1.5x | - | 2.0x | 2.2x | 2.9x | - |
| EV / EBITDA | 86.8x | - | 44.8x | - | - | - | 134.0x | 43.2x | 51.9x | - |
| Growth | ||||||||||
| Revenue growth (YoY) | 1.0% | - | -0.4% | 5.0% | 1.3% | - | 0.9% | -6.4% | -12.1% | - |
| Revenue CAGR (3y) | -3.5% | - | -5.6% | -5.5% | -8.1% | - | -3.7% | -2.4% | -2.0% | - |
| Revenue CAGR (5y) | -0.8% | - | 3.9% | 8.1% | 0.9% | - | 1.5% | 1.8% | -0.4% | - |
| Gross profit growth (YoY) | -10.2% | - | -18.5% | -9.2% | -17.5% | - | 1.8% | -25.4% | -22.3% | - |
| Operating income growth (YoY) | - | - | - | - | - | - | - | - | -61.3% | - |
| Net income growth (YoY) | -625.0% | - | - | - | - | - | - | - | -64.1% | - |
| EPS growth (YoY) | -533.3% | - | - | - | - | - | - | - | -64.6% | - |
| EPS CAGR (3y) | - | - | -35.9% | - | - | - | - | 5.7% | -15.8% | - |
| EPS CAGR (5y) | - | - | -2.8% | - | - | - | - | -4.2% | -9.2% | - |
| FCF growth (YoY) | 52.6% | - | - | - | 50.0% | - | - | - | -86.7% | - |
| FCF CAGR (5y) | - | - | - | - | - | - | - | - | - | - |
| Book value growth (YoY) | -62.9% | -58.6% | -54.6% | -67.2% | -23.0% | -18.0% | -13.0% | -10.5% | -38.7% | -33.4% |
Sales by segment
From XBRL dimensional facts in the 10-K period ending 2025-12-31.
Business segments
$11.62B totalAll Segments$5.76B · 49.6%
Titanium Technologies$2.43B · 20.9%
Thermal And Specialized Solutions$2.07B · 17.8%
Advanced Performance Materials$1.26B · 10.9%
Other Non-Reportable Segment$50.00M · 0.4%
All Other Segments$50.00M · 0.4%
Product / service
$5.81B totalTitanium Dioxide$2.33B · 40.1%
Opteon Refrigerants$1.26B · 21.8%
Advanced Materials$753.00M · 13.0%
Performance Solutions$510.00M · 8.8%
Freon Refrigerants$428.00M · 7.4%
Foam Propellants And Other$374.00M · 6.4%
Minerals And Other$98.00M · 1.7%
Performance Chemicals And Intermediates$50.00M · 0.9%
Geographic
$2.07B totalNorth America$1.13B · 54.5%
EMEA$381.00M · 18.4%
Latin America$325.00M · 15.7%
Asia Pacific$235.00M · 11.4%
Peer comparison
Same SIC group: Chemicals & Allied Products
Comparing Chemours Co against the 5 most active filers in the same SIC group.
Dividends
$0.35/share trailing 12 months · -58.0% YoY
| Ex-date | Per share |
|---|---|
| May 15, 2026 | $0.0880 |
| Feb 27, 2026 | $0.0880 |
| Nov 14, 2025 | $0.0880 |
| Aug 15, 2025 | $0.0880 |
| May 16, 2025 | $0.0880 |
| Feb 28, 2025 | $0.2500 |
| Nov 15, 2024 | $0.2500 |
| Aug 15, 2024 | $0.2500 |
| May 14, 2024 | $0.2500 |
| Feb 23, 2024 | $0.2500 |
| Nov 14, 2023 | $0.2500 |
| Aug 14, 2023 | $0.2500 |
| May 12, 2023 | $0.2500 |
| Feb 23, 2023 | $0.2500 |
| Nov 14, 2022 | $0.2500 |
| Aug 12, 2022 | $0.2500 |
| May 13, 2022 | $0.2500 |
| Feb 24, 2022 | $0.2500 |
| Nov 12, 2021 | $0.2500 |
| Aug 13, 2021 | $0.2500 |
| May 14, 2021 | $0.2500 |
| Feb 25, 2021 | $0.2500 |
| Nov 13, 2020 | $0.2500 |
| Aug 14, 2020 | $0.2500 |